TY - JOUR
AU - Quashie, Peter Kojo
AU - Mutungi, Joe Kimanthi
AU - Dzabeng, Francis
AU - Oduro-Mensah, Daniel
AU - Opurum, Precious C.
AU - Tapela, Kesego
AU - Udoakang, Aniefiok John
AU - Asante, Ivy
AU - Paemka, Lily
AU - Kumi-Ansah, Frederick
AU - Quaye, Osbourne
AU - Amoako, Emmanuela
AU - Armah, Ralph
AU - Kilba, Charlyne
AU - Boateng, Nana Afia
AU - Ofori, Michael
AU - Kyei, George B.
AU - Bediako, Yaw
AU - Ndam, Nicaise
AU - Abugri, James
AU - Ansah, Patrick
AU - Ampofo, William K.
AU - Mutapi, Francisca
AU - Awandare, Gordon A.
PY - 2021
DA - July
TI - Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana
JO - Wellcome Open Research
VL - 6
DO - https://doi.org/10.12688/wellcomeopenres.16890.2
AB - Background We set out to estimate the community-level exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana. Methods Phased seroprevalence studies of 2729 participants at selected locations across Ghana were conducted. Phase I (August 2020) sampled 1305 individuals at major markets/lorry stations, shopping malls, hospitals and research institutions involved in coronavirus disease 2019 (COVID-19) work. The study utilized a lateral flow rapid diagnostic test (RDT) which detected IgM and IgG antibodies against SARS-CoV-2 nucleocapsid protein. Results During Phase I, 252/1305 (19%) tested positive for IgM or IgG or both. Exposure was significantly higher at markets/lorry stations (26.9%) compared to malls (9.4%), with 41–60-year group demonstrating highest seropositivity (27.2%). Exposure was higher in participants with no formal education (26.2%) than those with tertiary education (13.1%); and higher in informally employed workers (24.0%) than those in the formal sector (15.0%). Results from phases II and III, in October and December 2020 respectively, implied either reduced transmissions or loss of antibody expression in some participants. The Upper East region showed the lowest seropositivity (2%). Phase IV, in February 2021, showed doubled seropositivity in the upper income bracket (26.2%) since August 2020, reflective of Ghana’s second wave of symptomatic COVID-19 cases. This suggested that high transmission rates had overcome the initial socioeconomic stratification of exposure risk. Reflective of second wave hospitalisation trends, the 21–40 age group demonstrated modal seropositivity (24.9) in Phase IV whilst 40–60 years and 60+ previously demonstrated highest prevalence. Conclusions Overall, the data indicates higher COVID-19 seroprevalence than officially acknowledged, likely implying a considerably lower-case fatality rate than the current national figure of 0.84%. The data also suggests that COVID-19 is predominantly asymptomatic COVID-19 in Ghana. The observed trends mimic clinical trends of infection and imply that the methodology used was appropriate.
PB - Wellcome Open Research
UR - https://www.research.ed.ac.uk/en/publications/f415a385-1961-4a58-9474-cf55af65aef4
KW - Coronavirus (COVID-19)
ER